Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) have been given an average recommendation of “Moderate Buy” by the twelve research firms that are presently covering the stock, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12 month price target among brokers that have covered the stock in the last year is $15.79.

SBRA has been the topic of a number of research reports. Scotiabank lifted their price target on shares of Sabra Health Care REIT from $14.00 to $15.00 and gave the company a “sector perform” rating in a research note on Wednesday, May 15th. Truist Financial raised their target price on shares of Sabra Health Care REIT from $15.00 to $16.00 and gave the company a “buy” rating in a research report on Thursday.

Sabra Health Care REIT Stock Performance

Shares of SBRA opened at $15.40 on Friday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 4.33 and a current ratio of 4.33. Sabra Health Care REIT has a twelve month low of $11.57 and a twelve month high of $15.43. The firm’s 50 day moving average price is $14.37 and its two-hundred day moving average price is $14.11. The firm has a market cap of $3.57 billion, a P/E ratio of 77.00, a PEG ratio of 2.37 and a beta of 1.22.

Sabra Health Care REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, May 31st. Investors of record on Monday, May 20th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 7.79%. The ex-dividend date of this dividend was Friday, May 17th. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 600.00%.

Insider Buying and Selling at Sabra Health Care REIT

In related news, Director Catherine Cusack acquired 7,000 shares of the company’s stock in a transaction dated Wednesday, May 22nd. The shares were bought at an average cost of $14.43 per share, with a total value of $101,010.00. Following the completion of the transaction, the director now directly owns 46,385 shares of the company’s stock, valued at $669,335.55. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of SBRA. Tennessee Valley Asset Management Partners acquired a new position in Sabra Health Care REIT in the 4th quarter valued at about $25,000. GAMMA Investing LLC bought a new stake in Sabra Health Care REIT in the 4th quarter valued at about $33,000. Neo Ivy Capital Management bought a new stake in Sabra Health Care REIT in the 4th quarter valued at about $41,000. Principal Securities Inc. bought a new stake in Sabra Health Care REIT in the 4th quarter valued at about $46,000. Finally, Newbridge Financial Services Group Inc. bought a new stake in Sabra Health Care REIT in the 4th quarter valued at about $56,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.